<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Various therapeutic methods have been attempted for <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, but the development of more effective methods is still awaited </plain></SENT>
<SENT sid="1" pm="."><plain>We have investigations of the effect of <z:chebi fb="1" ids="29864">mannitol</z:chebi> in preventing the development of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and have reported it effects in clinical cases of operated <z:hpo ids='HP_0004944'>cerebral aneurysms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In recent years, our attention has been drawn to the so-called red cell substitute, perfluorochemicals (FC), which has a high oxygen-carrying capacity and a small particle less than 0.1 mu </plain></SENT>
<SENT sid="3" pm="."><plain>In the present studies, using infarction models in dogs which have previously developed and reported, observations are made on the recovery of brain electrical activity in <z:e sem="disease" ids="C0264097" disease_type="Disease or Syndrome" abbrv="">sever</z:e> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, suppressing <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> following recirculation of cerebral blood flow and protection upon the hemorrhagic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, due to administration of <z:chebi fb="1" ids="29864">mannitol</z:chebi> or FC </plain></SENT>
<SENT sid="4" pm="."><plain>These experimental results indicate that the combined administration of <z:chebi fb="1" ids="29864">mannitol</z:chebi> and FC is effective in protecting the brain from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>